Literature DB >> 27521724

Access of HIV-2 to CD169-dependent dendritic cell-mediated trans infection pathway is attenuated.

Suzanne D G Kijewski1, Hisashi Akiyama2, Amin Feizpour3, Caitlin M Miller4, Nora-Guadalupe P Ramirez5, Björn M Reinhard6, Suryaram Gummuluru7.   

Abstract

The mechanisms behind the low viral loads and lower mortality rates of HIV-2(+) individuals remain unknown. We hypothesized that reduced interaction of HIV-2 with CD169, the primary HIV-1 attachment factor on monocyte-derived dendritic cells (DCs) that targets captured virus particles to the trans infection pathway, contributes to its diminished pathogenic phenotype in vivo. We observed a significant decrease in capture of HIV-2 Gag-eGFP virus-like particles (VLPs) and infectious GFP-containing HIV-2 particles compared to corresponding HIV-1 particles by CD169(+) mature DCs. Interestingly, there was decreased co-localization of HIV-2 with HIV-1 Gag at plasma membrane microdomains in virus producer cells which correlated with reduced incorporation of GM3, the CD169 ligand, in HIV-2 virions, and reduction in mature DC-mediated HIV-2 trans infection compared to HIV-1. We conclude that limited interaction of HIV-2 with CD169 diminishes virus access to the mature DC-mediated trans infection pathway and might result in attenuated HIV-2 dissemination in vivo.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD169; Cell-associated virus transfer; Dendritic cells; GM3; HIV-2; Trans infection; Virus capture

Mesh:

Substances:

Year:  2016        PMID: 27521724      PMCID: PMC5026622          DOI: 10.1016/j.virol.2016.07.029

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  52 in total

1.  Tracing the origin and history of the HIV-2 epidemic.

Authors:  Philippe Lemey; Oliver G Pybus; Bin Wang; Nitin K Saksena; Marco Salemi; Anne-Mieke Vandamme
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-12       Impact factor: 11.205

Review 2.  The origins of acquired immune deficiency syndrome viruses: where and when?

Authors:  P M Sharp; E Bailes; R R Chaudhuri; C M Rodenburg; M O Santiago; B H Hahn
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-06-29       Impact factor: 6.237

3.  DC-SIGN interactions with human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus.

Authors:  S Pöhlmann; F Baribaud; B Lee; G J Leslie; M D Sanchez; K Hiebenthal-Millow; J Münch; F Kirchhoff; R W Doms
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Direct evidence of lower viral replication rates in vivo in human immunodeficiency virus type 2 (HIV-2) infection than in HIV-1 infection.

Authors:  Adam MacNeil; Abdoulaye Dieng Sarr; Jean-Louis Sankalé; Seema Thakore Meloni; Souleymane Mboup; Phyllis Kanki
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

5.  Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.

Authors:  A Mörner; A Björndal; J Albert; V N Kewalramani; D R Littman; R Inoue; R Thorstensson; E M Fenyö; E Björling
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment.

Authors:  Heiko Hauser; Lisa A Lopez; Su Jung Yang; Jill E Oldenburg; Colin M Exline; John C Guatelli; Paula M Cannon
Journal:  Retrovirology       Date:  2010-06-07       Impact factor: 4.602

7.  Dendritic cells are less susceptible to human immunodeficiency virus type 2 (HIV-2) infection than to HIV-1 infection.

Authors:  Melody G Duvall; Karin Loré; Hetty Blaak; David A Ambrozak; William C Adams; Kathlyn Santos; Christof Geldmacher; John R Mascola; Andrew J McMichael; Assan Jaye; Hilton C Whittle; Sarah L Rowland-Jones; Richard A Koup
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

8.  Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.

Authors:  Hisashi Akiyama; Caitlin Miller; Hiren V Patel; Steven C Hatch; Jacob Archer; Nora-Guadalupe P Ramirez; Suryaram Gummuluru
Journal:  J Virol       Date:  2014-05-28       Impact factor: 5.103

9.  Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patients.

Authors:  T Tai; L D Cahan; J C Paulson; R E Saxton; R F Irie
Journal:  J Natl Cancer Inst       Date:  1984-09       Impact factor: 13.506

Review 10.  HIV-2: the forgotten AIDS virus.

Authors:  Thushan I de Silva; Matthew Cotten; Sarah L Rowland-Jones
Journal:  Trends Microbiol       Date:  2008-10-27       Impact factor: 17.079

View more
  4 in total

Review 1.  In Vivo Imaging-Driven Approaches to Study Virus Dissemination and Pathogenesis.

Authors:  Pradeep D Uchil; Kelsey A Haugh; Ruoxi Pi; Walther Mothes
Journal:  Annu Rev Virol       Date:  2019-07-05       Impact factor: 10.431

2.  CD169-mediated restrictive SARS-CoV-2 infection of macrophages induces pro-inflammatory responses.

Authors:  Sallieu Jalloh; Judith Olejnik; Jacob Berrigan; Annuurun Nisa; Ellen L Suder; Hisashi Akiyama; Maohua Lei; Sanjay Tyagi; Yuri Bushkin; Elke Mühlberger; Suryaram Gummuluru
Journal:  bioRxiv       Date:  2022-03-30

3.  Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles.

Authors:  Susana Benet; Cristina Gálvez; Francis Drobniewski; Irina Kontsevaya; Lilibeth Arias; Marta Monguió-Tortajada; Itziar Erkizia; Victor Urrea; Ruo-Yan Ong; Marina Luquin; Maeva Dupont; Jakub Chojnacki; Judith Dalmau; Paula Cardona; Olivier Neyrolles; Geanncarlo Lugo-Villarino; Christel Vérollet; Esther Julián; Hansjakob Furrer; Huldrych F Günthard; Paul R Crocker; Gustavo Tapia; Francesc E Borràs; Jacques Fellay; Paul J McLaren; Amalio Telenti; Pere-Joan Cardona; Bonaventura Clotet; Cristina Vilaplana; Javier Martinez-Picado; Nuria Izquierdo-Useros
Journal:  J Extracell Vesicles       Date:  2021-01-14

4.  A Protective Role for the Lectin CD169/Siglec-1 against a Pathogenic Murine Retrovirus.

Authors:  Pradeep D Uchil; Ruoxi Pi; Kelsey A Haugh; Mark S Ladinsky; John D Ventura; Brad S Barrett; Mario L Santiago; Pamela J Bjorkman; George Kassiotis; Xaver Sewald; Walther Mothes
Journal:  Cell Host Microbe       Date:  2018-12-27       Impact factor: 21.023

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.